MTHFD2 and breast cancer: As a mechanism, the authors revealed that SIRT4 deacetylation of MTHFD2 destabilizes MTHFD2 and causes its proteasomal degradation, leading to NADPH reduction and intracellular ROS accumulation in the breast tumors which, in turn, inhibits the proliferation of the breast cancer cells [73].